Huaren Pharmaceutical Co (SZSE:300110) Operating Cash Flow per Share : ¥0.26 (TTM As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Huaren Pharmaceutical Co Operating Cash Flow per Share?

Huaren Pharmaceutical Co's operating cash flow per share for the three months ended in Mar. 2025 was ¥0.08. Huaren Pharmaceutical Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.26.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Huaren Pharmaceutical Co was -11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Huaren Pharmaceutical Co's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Huaren Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 139.90% per year. The lowest was -43.30% per year. And the median was 21.25% per year.

SZSE:300110's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 8.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Huaren Pharmaceutical Co Operating Cash Flow per Share Historical Data

The historical data trend for Huaren Pharmaceutical Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huaren Pharmaceutical Co Operating Cash Flow per Share Chart

Huaren Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.01

-0.49

0.18

0.26

0.27

Huaren Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.09	0.04	0.11	0.03	0.08

Competitive Comparison of Huaren Pharmaceutical Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Huaren Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Huaren Pharmaceutical Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Huaren Pharmaceutical Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	322.36	/	1182.169
	=	0.27

Huaren Pharmaceutical Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	96.676	/	1178.562
	=	0.08

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.26

Huaren Pharmaceutical Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Huaren Pharmaceutical Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Huaren Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huaren Pharmaceutical Co Ltd (SZSE:300110) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100

Website

http://www.qdhuaren.com

Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.

Executives

Yang Xiao Dong	Director
Bo Guo Xiu	Executives
Zhou Xi Jian	Director
Mao Yu Wei	Supervisors
Chu Xiao Jun	Executives
Zhou Qiang	Directors, executives
Ji Sheng Bin	Executives
Xiao Wei Wen	Executives
Shen Hong Ce	Executives
Li Xiao Li	Executives
Liu Qian	Executives
Wang Wen Ping	Executives
Liang Fu You	Director
Liang Fu Dong	Director
Gong Ling	Secretary Dong

Huaren Pharmaceutical Co Headlines

No Headlines